Clarendon Private LLC Has $749,000 Stake in UnitedHealth Group Incorporated $UNH

Clarendon Private LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.4% during the second quarter, Holdings Channel.com reports. The firm owned 2,402 shares of the healthcare conglomerate’s stock after selling 248 shares during the period. Clarendon Private LLC’s holdings in UnitedHealth Group were worth $749,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Citizens National Bank Trust Department lifted its holdings in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after buying an additional 170 shares during the period. Caitlin John LLC lifted its holdings in UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after buying an additional 111 shares during the period. Triumph Capital Management acquired a new position in UnitedHealth Group in the second quarter valued at approximately $1,324,000. Wealth Effects LLC increased its stake in UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares in the last quarter. Finally, Arlington Partners LLC bought a new stake in UnitedHealth Group in the second quarter valued at approximately $2,229,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Mizuho upped their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. KeyCorp upped their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday. Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Finally, Barclays increased their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus price target of $383.09.

UnitedHealth Group Stock Down 3.6%

UnitedHealth Group stock opened at $354.30 on Friday. The company has a market cap of $320.88 billion, a P/E ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a fifty day simple moving average of $318.21 and a 200 day simple moving average of $349.25. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.